Washington, USA
+919405476170
+919405476170

Pomavia 2mg Capsule Supplier USA | Pharmaceutical Exporter from India

Pomavia 2 mg Capsule: Advanced Pomalidomide Therapy for Relapsed Oncology Care



Are you seeking a trusted Pomavia 2 mg capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced hematology and oncology medications. We maintain a high-authority, regulatory-compliant supply chain serving the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that life-saving cancer treatments reach healthcare providers with pharmaceutical-grade integrity and efficient global logistics.




Detailed Product Overview: What is Pomavia 2mg?


Pomavia 2mg is a high-potency oral capsule containing the active pharmaceutical ingredient Pomalidomide. It is a third-generation immunomodulatory agent (IMiD) derived from thalidomide, specifically engineered to be more potent and have a more favorable side-effect profile than its predecessors.

The 2 mg strength is often used as a starting dose or in combination therapy for patients who have exhausted other treatment lines. Manufactured under strict quality controls in India, Pomavia 2mg represents the pinnacle of pharmaceutical engineering for patients battling refractory blood cancers.




Primary Therapeutic Indications: 

Pomavia 2 mg is clinically indicated for:

  1. Relapsed and Refractory Multiple Myeloma (RRMM): Specifically for adult patients who have received at least two prior therapies, including both lenalidomide and a proteasome inhibitor, and have demonstrated disease progression on or within 60 days of completion of the last therapy.

  2. Combination Therapy: Often prescribed in conjunction with low-dose dexamethasone to synergistically enhance the anti-tumor effect.

  3. Kaposi Sarcoma: In specific clinical scenarios for patients with AIDS-related or HIV-negative Kaposi Sarcoma where other systemic therapies have failed.


Mechanism of Action: How Pomavia 2 mg Works

Pomavia (Pomalidomide) works through a sophisticated, triple-action mechanism to target malignant cells:

  • Direct Anti-Tumor Activity: It binds directly to the protein Cereblon, part of an E3 ubiquitin ligase complex. This leads to the degradation of specific transcription factors (Ikaros and Aiolos), which triggers apoptosis (programmed cell death) in myeloma cells.

  • Immune System Augmentation: It enhances the activity of T-cells and Natural Killer (NK) cells, empowering the patient's own immune system to identify and destroy cancer cells more effectively.

  • Anti-Angiogenesis: It inhibits the growth of new blood vessels that tumors rely on for nutrients and oxygen, effectively starving the cancerous growth.



Administration and Safety Guidelines: 


  • Standard Dosage: Typically taken as one 2 mg capsule daily on days 1–21 of repeated 28-day cycles. Dosing must be strictly supervised by a consultant oncologist.

  • Instructions: Capsules must be swallowed whole with water. Do not break, chew, or open the capsules. It can be taken with or without food.

  • Key Precautions:

    • Pregnancy Warning: Pomalidomide is contraindicated in pregnancy due to the risk of severe birth defects. Strict adherence to pregnancy prevention programs is mandatory.

    • Venous Thromboembolism (VTE): Patients are often prescribed blood thinners concurrently to reduce the risk of deep vein thrombosis or pulmonary embolism.

    • Hematologic Monitoring: Regular blood tests are required to monitor for neutropenia (low white blood cells) and thrombocytopenia.



Why Source Pomavia 2 mg from Ernest Oncology?

  • Strategic Indian Exporter: Direct access to GMP-certified manufacturing hubs in India, ensuring 100% authenticity and cost-effective bulk pricing for the international B2B market.

  • Global Logistics Mastery: Proven expertise in navigating the complex regulatory and customs landscapes of the UK, USA, UAE, Australia, and South Africa.

  • Cold Chain & Security: Professional-grade packaging and tracked shipping ensure the medication remains stable and secure from our facility to your destination.

  • Bulk Supply Reliability: We specialize in large-scale exports for oncology hospitals and government tenders, ensuring treatment continuity for patients worldwide.


📞 Contact Ernest Oncology — Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Websites:

📧 Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

 📲 WhatsApp: +91 93599 02383 

🔗 Direct Link: Chat on WhatsApp

 2026-04-06T10:13:19

Keywords